News

Keeping Up with GAIA-BT

GAIA-BT Signs Letter of Intent with ProEn Therapeutics
for Joint R&D

GAIA-BT, GBSA-selected Gyeonggi AI
Membership Company

May 19, 2026 | GAIA-BT

[Image] GAIA-BT Partners with ProEn Therapeutics for Joint R&D

On May 19th (Tuesday), GAIA-BT and ProEn Therapeutics, a biotech developing next-generation targeted therapies for cancer, signed a letter of intent to kick-off a collaborative partnership for joint R&D.

#714, 52 Geumto-ro, Sujeong-gu, Seongnam-si, Gyeonggi-do, KR (13453)

MEDIA

#714, 52 Geumto-ro, Sujeong-gu, Seongnam-si,
Gyeonggi-do, KR (13453)

QUICK MENU

#714, 52 Geumto-ro, Sujeong-gu, Seongnam-si, Gyeonggi-do, KR (13453)

News

News

Keeping Up with GAIA-BT

Keeping Up with GAIA-BT

GAIA-BT Signs Letter of Intent with ProEn Therapeuticsfor Joint R&D

GAIA-BT Signs Letter of Intent with ProEn Therapeutics
for Joint R&D